Product

SA58

Aliases

SA58 Nasal Spray

2 clinical trials

1 indication

Indication

Clinical trial

A Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray, Among Close Contact With COVID-19 People

Status: Active (not recruiting), Estimated PCD: 2022-12-30

Clinical trial

Safety and Effectiveness of SA58 Nasal Spray Against COVID-19 Infection in Medical Personnel：An Open-label, Blank-controlled Study

Status: Active (not recruiting), Estimated PCD: 2022-12-31